Nov 8 (Reuters) - Hoth Therapeutics Inc HOTH.O :
* HOTH THERAPEUTICS INKS API AND DRUG PRODUCT CONTRACTS WITH WUXI STA TO ADVANCE MANUFACTURING OF HT-KIT CANCER THERAPEUTIC
* HOTH THERAPEUTICS INC - HT-KIT API PROCESS DEVELOPMENT FOR MANUFACTURING IS ALREADY UNDERWAY, EXPECTING TO YIELD SMALL SCALE MATERIAL IN Q1 2022
* HOTH THERAPEUTICS INC - INTENDS TO DEVELOP HT-KIT AS PARENTERAL FORMULATION FOR INJECTION
* HOTH THERAPEUTICS INC - AFTER COMPLETION OF FORMULATION DEVELOPMENT, CO INTENDS TO PURSUE A PRE-IND MEETING WITH US FDA
Source text for Eikon: ID:nPn7pcRHra Further company coverage: HOTH.O
((Reuters.Briefs@thomsonreuters.com;))